Colleen M Culley1,2, Subashan Perera3,4, Zachary A Marcum5, Sandra L Kane-Gill1,2,6, Steven M Handler2,3. 1. Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania. 2. Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, Pennsylvania. 3. Division of Geriatric Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. 4. Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania. 5. Department of Pharmacy, School of Pharmacy, University of Washington, Seattle, Washington. 6. Department of Critical Care Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Abstract
OBJECTIVES: To determine whether a clinical surveillance system could be used to detect drug-associated hypoglycemia events and determine their incidence in nursing home (NH) residents. DESIGN: Retrospective cohort. SETTING: Four NHs in western Pennsylvania. PARTICIPANTS: Any resident of the four NHs who had a computer-generated alert detecting potential drug-associated hypoglycemia over a 6-month period were included. MEASUREMENTS: Descriptive statistics were used to summarize all variables, including the frequency and distribution of alert type according to glucose threshold. Analyses were conducted according to numbers of alerts and residents. The medications associated with the drug-associated hypoglycemia alerts were identified, and frequency of their inclusion in alerts was calculated. Additional calculations included time to drug-associated hypoglycemic event alert from date of admission and frequency of events associated with postacute, short-stay (≤35 days) admissions. RESULTS: Seven hundred seventy-two alerts involving 141 residents were detected. Ninety (63.8%) residents had a glucose level of 55 mg/dL or less, and 42 (29.8%) had a glucose level of 40 mg/dL or less. Insulin orders were associated with 762 (98.7%) alerts. Overall incidence of drug-associated hypoglycemia events was 9.5 per 1,000 resident-days. CONCLUSION: Hypoglycemia can be detected using a clinical surveillance system. This evaluation found a high incidence of drug-associated hypoglycemia in a general NH population. Future studies are needed to determine the potential benefits of use of a surveillance system in real-time detection and management of hypoglycemia in NHs.
OBJECTIVES: To determine whether a clinical surveillance system could be used to detect drug-associated hypoglycemia events and determine their incidence in nursing home (NH) residents. DESIGN: Retrospective cohort. SETTING: Four NHs in western Pennsylvania. PARTICIPANTS: Any resident of the four NHs who had a computer-generated alert detecting potential drug-associated hypoglycemia over a 6-month period were included. MEASUREMENTS: Descriptive statistics were used to summarize all variables, including the frequency and distribution of alert type according to glucose threshold. Analyses were conducted according to numbers of alerts and residents. The medications associated with the drug-associated hypoglycemia alerts were identified, and frequency of their inclusion in alerts was calculated. Additional calculations included time to drug-associated hypoglycemic event alert from date of admission and frequency of events associated with postacute, short-stay (≤35 days) admissions. RESULTS: Seven hundred seventy-two alerts involving 141 residents were detected. Ninety (63.8%) residents had a glucose level of 55 mg/dL or less, and 42 (29.8%) had a glucose level of 40 mg/dL or less. Insulin orders were associated with 762 (98.7%) alerts. Overall incidence of drug-associated hypoglycemia events was 9.5 per 1,000 resident-days. CONCLUSION:Hypoglycemia can be detected using a clinical surveillance system. This evaluation found a high incidence of drug-associated hypoglycemia in a general NH population. Future studies are needed to determine the potential benefits of use of a surveillance system in real-time detection and management of hypoglycemia in NHs.
Authors: Christopher A Newton; Saira Adeel; Shadi Sadeghi-Yarandi; Winter Powell; Alexandra Migdal; Dawn Smiley; Darin Olson; Rakhee Chambria; Ingrid Pinzon; Marcos Toyoshima; Zobair Nagamia; Limin Peng; Theodore Johnson; Guillermo E Umpierrez Journal: J Am Med Dir Assoc Date: 2013-09-20 Impact factor: 4.669
Authors: Sandra L Kane-Gill; Shyam Visweswaran; Melissa I Saul; An-Kwok Ian Wong; Louis E Penrod; Steven M Handler Journal: Int J Med Inform Date: 2011-05-31 Impact factor: 4.046
Authors: C Rachel Kilpatrick; Michael B Elliott; Elizabeth Pratt; Stephen J Schafers; Mary Clare Blackburn; Kevin Heard; Janet B McGill; Mark Thoelke; Garry S Tobin Journal: J Hosp Med Date: 2014-06-05 Impact factor: 2.960
Authors: Elizabeth R Seaquist; John Anderson; Belinda Childs; Philip Cryer; Samuel Dagogo-Jack; Lisa Fish; Simon R Heller; Henry Rodriguez; James Rosenzweig; Robert Vigersky Journal: Diabetes Care Date: 2013-04-15 Impact factor: 19.112